Data as of 3:59pm ET
| -7.50 / -2.21%|
The 24 analysts offering 12-month price forecasts for Biogen Idec Inc have a median target of 329.50, with a high estimate of 416.00 and a low estimate of 262.00. The median estimate represents a -0.77% decrease from the last price of 332.05.
The current consensus among 29 polled investment analysts is to Buy stock in Biogen Idec Inc. This rating has held steady since February, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.